pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Streptococcus vaccine
drug · vaccine component
save

Streptococcus vaccine

Phase 2updated 3mo ago
by Minervax ApS🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 1
  • tagVaccine1 co-mentions · 1 sources

Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for pneumococcal infection and 1 investigational indication.

all catalysts(0)

nothing on the calendar yet

Trials studying Streptococcus vaccine

  • phase3BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babiesrecruitingn=6,000
  • phase2Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infantscompletedn=1,208
  • phase2Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Womencompletedn=306

News(0)

no news has mentioned this drug yet

trade names
Corynebacterium diphtheriae crm197 protein component of capvaxive, Prevenar, Prevenar 13, Prevenar 20 (previously apexxnar), Streptococcus pneumoniae type 10a capsular polysaccharide diphtheria crm197 protein conjugate antigen component of capvaxive, Streptococcus pneumoniae type 11a capsular polysaccharide diphtheria crm197 protein conjugate antigen component of capvaxive
indication
Streptococcal Infections
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?